Cytoplasmic LIF Reprograms Invasive Mode to Enhance NPC Dissemination Through Modulating YAP1-FAK/PXN Signaling

Overview

Journal Nat Commun

Specialty Biology

Date 2018 Dec 4

PMID 30504771

Citations 18

Authors

Shu-Chen Liu

Tien Hsu

Yu-Sun Chang

An-Ko Chung

Shih Sheng Jiang

Chun-Nan OuYang

Chiou-Hwa Yuh

Chuen Hsueh

Ya-Ping Liu

Ngan-Ming Tsang

Affiliations

Soon will be listed here.

Abstract

Metastasis remains a clinically unsolved issue in nasopharyngeal carcinoma. Here, we report that higher levels of cytoplasmic leukemia inhibitory factor (LIF) and LIF receptor are correlated with poorer metastasis/recurrence-free survival. Further, single nucleotide variations and signal peptide mutation of LIF are identified in NPC. Cytoplasmic LIF reprograms the invasive mode from collective to mesenchymal migration via acquisition of EMT and invadopodia-associated characteristics. Higher cytoplasmic LIF enhances cancer vascular dissemination and local invasion mechanistically through modulation of YAP1-FAK/PXN signaling. Immunohistochemical analyses of NPC biopsies reveal a positive correlation of cytoplasmic LIF expression with focal adhesion kinases. Pharmaceutical intervention with AZD0530 markedly reverses LIF-mediated cancer dissemination and local invasion through promotion of cytoplasmic accumulation of YAP1 and suppression of focal adhesion kinases. Given the significant role of LIF/YAP1-focal adhesion signaling in cancer dissemination, targeting of this pathway presents a promising opportunity to block metastasis.

Citing Articles

The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer.

Zhong B, Du J, Liu F, Sun S MedComm (2020). 2025; 6(3):e70128.

PMID: 40066231 PMC: 11892025. DOI: 10.1002/mco2.70128.

A 3-gene signature comprising CDH4, STAT4 and EBV-encoded LMP1 for early diagnosis and predicting disease progression of nasopharyngeal carcinoma.

Liu S, Wang C, Liu T, Tsang N, Sui Y, Juang J Discov Oncol. 2023; 14(1):119.

PMID: 37393410 PMC: 10314886. DOI: 10.1007/s12672-023-00735-x.

Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge.

Peng Z, Wang Y, Fan R, Gao K, Xie S, Wang F Cancers (Basel). 2022; 14(17).

PMID: 36077648 PMC: 9454547. DOI: 10.3390/cancers14174111.

ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.

Werner M, Dyas A, Parfentev I, Schmidt G, Mieczkowska I, Muller-Kirschbaum L Cell Death Dis. 2022; 13(9):762.

PMID: 36057630 PMC: 9440919. DOI: 10.1038/s41419-022-05197-7.

Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.

Lee P, Sui Y, Liu T, Tsang N, Huang C, Lin T J Exp Clin Cancer Res. 2022; 41(1):254.

PMID: 35986369 PMC: 9392321. DOI: 10.1186/s13046-022-02456-5.

References

Hughes A, Ralston S, Marken J, Bell C, MacPherson H, Wallace R . Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 1999; 24(1):45-8. DOI: 10.1038/71667. View

Johnson R, Finger E, Olcina M, Vilalta M, Aguilera T, Miao Y . Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016; 18(10):1078-1089. PMC: 5357601. DOI: 10.1038/ncb3408. View

Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

Gimona M, Buccione R, Courtneidge S, Linder S . Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol. 2008; 20(2):235-41. DOI: 10.1016/j.ceb.2008.01.005. View

Bay J, Patterson B, Teng N . Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells. Infect Dis Obstet Gynecol. 2011; 2011:463081. PMC: 3124004. DOI: 10.1155/2011/463081. View

Zhao B, Li L, Wang L, Wang C, Yu J, Guan K . Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012; 26(1):54-68. PMC: 3258966. DOI: 10.1101/gad.173435.111. View

Wysoczynski M, Miekus K, Jankowski K, Wanzeck J, Bertolone S, Janowska-Wieczorek A . Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res. 2007; 67(5):2131-40. DOI: 10.1158/0008-5472.CAN-06-1021. View

Wu H, Cheng X, Jing X, Ji X, Chen X, Zhang Y . LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(9 Pt B):2769-2784. DOI: 10.1016/j.bbadis.2018.05.004. View

Kamohara H, Takahashi M, Ishiko T, Ogawa M, Baba H . Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor. Int J Oncol. 2007; 31(3):627-32. View

10.

Tomida M . Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells. Leuk Lymphoma. 2000; 37(5-6):517-25. DOI: 10.3109/10428190009058503. View

11.

Murphy D, Courtneidge S . The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol. 2011; 12(7):413-26. PMC: 3423958. DOI: 10.1038/nrm3141. View

12.

Pan D . The hippo signaling pathway in development and cancer. Dev Cell. 2010; 19(4):491-505. PMC: 3124840. DOI: 10.1016/j.devcel.2010.09.011. View

13.

Tsai J, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27(20):2192-206. PMC: 3814640. DOI: 10.1101/gad.225334.113. View

14.

Arthan D, Hong S, Park J . Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells. Cancer Lett. 2010; 297(1):31-41. DOI: 10.1016/j.canlet.2010.04.021. View

15.

Penuelas S, Anido J, Prieto-Sanchez R, Folch G, Barba I, Cuartas I . TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 2009; 15(4):315-27. DOI: 10.1016/j.ccr.2009.02.011. View

16.

Lumachi F, Basso S, Orlando R . Cytokines, thyroid diseases and thyroid cancer. Cytokine. 2010; 50(3):229-33. DOI: 10.1016/j.cyto.2010.03.005. View

17.

Mikelonis D, Jorcyk C, Tawara K, Oxford J . Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology. Orphanet J Rare Dis. 2014; 9:34. PMC: 3995696. DOI: 10.1186/1750-1172-9-34. View

18.

Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R, Estrov Z . Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int J Cancer. 1996; 66(4):515-9. DOI: 10.1002/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6. View

19.

Guran T, Guran O, Paketci C, Kipoglu O, Firat I, Turan S . Effects of leukemia inhibitory receptor gene mutations on human hypothalamo-pituitary-adrenal function. Pituitary. 2014; 18(4):456-60. DOI: 10.1007/s11102-014-0594-5. View

20.

Pera M, Tam P . Extrinsic regulation of pluripotent stem cells. Nature. 2010; 465(7299):713-20. DOI: 10.1038/nature09228. View